GlassScriptPhysician profile
Mandeep S Sidhu
NPI 1225133754
$14,815.68
in general payments reported to CMS, 2019-2025
17 companies · $1,360 in 2025
The $1,360 reported for 2025 was more than what 77% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13K · 2020: $99.93 · 2022: $26.43 · 2023: $138 · 2024: $46.98 · 2025: $1,360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,545.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | $9,702.83 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $3,024.17 | 2019 | |
| Aop Health US, LLC | $1,000.56 | 2025 | Rapiblyk |
| Kowa Pharmaceuticals America, INC. | $362.67 | 2019 | |
| Novartis Pharmaceuticals Corporation | $211.62 | 2023-2025 | |
| Edwards Lifesciences Corporation | $111.74 | 2025 | Pascal |
| Medtronic USA, INC. | $99.93 | 2020 | |
| Abbott Laboratories | $79.32 | 2023-2025 | Navitor, Cardiomems |
| Medtronic, INC. | $45.57 | 2023-2024 | Symplicity G3, Pillcam |
| Boston Scientific Corporation | $44.77 | 2022-2025 | Bodyguardian |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.61 | 2019 | |
| Baxter Healthcare | $25.99 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Kiniksa Pharmaceuticals, LTD. | $19.84 | 2023 | Arcalyst |
| Novo Nordisk INC | $18.05 | 2025 | Wegovy |
| Cvrx, INC. | $14.46 | 2025 | Barostim Neo System |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.76 | 2019 | |
| Janssen Pharmaceuticals, INC | $12.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mandeep Sidhu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.